Search results
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoBio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2023 Earnings Call Transcript October 26, 2023 Bio-Rad...
Bio-Rad Laboratories Inc (BIO) Q3 2023 Earnings: A Detailed Review
GuruFocus.com via Yahoo Finance· 6 months agoThird-quarter 2023 total net sales decreased by 7.1% to $632.1 million compared to $680.8 million in...
Is Now An Opportune Moment To Examine Bio-Rad Laboratories, Inc. (NYSE:BIO)?
Simply Wall St. via Yahoo Finance· 3 months agoBio-Rad Laboratories, Inc. (NYSE:BIO), might not be a large cap stock, but it led the NYSE gainers...
Bio-Rad Laboratories Inc (BIO) Faces Headwinds in Q4, Yet Shows Resilience in Diagnostics Segment
GuruFocus.com via Yahoo Finance· 2 months agoRevenue: Q4 net sales decreased by 6.7% to $681.2 million; full-year sales down 4.7% to $2,671.3...
Is It Too Late To Consider Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?
Simply Wall St. via Yahoo Finance· 1 year agoToday we're going to take a look at the well-established Bio-Rad Laboratories, Inc. (NYSE:BIO). The...
Investors Aren't Entirely Convinced By Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Revenues
Simply Wall St. via Yahoo Finance· 4 months agoWith a median price-to-sales (or "P/S") ratio of close to 3.9x in the Life Sciences industry in the...
Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights The projected fair value for Bio-Rad Laboratories is US$399 based on 2 Stage Free Cash...
Is Bio-Rad Laboratories (BIO) Significantly Undervalued? An In-depth GF Value Analysis
GuruFocus.com via Yahoo Finance· 9 months agoOn August 4, 2023, Bio-Rad Laboratories Inc (NYSE:BIO) saw a daily gain of 3.5%, despite a reported...
Insider Sell: EVP, General Counsel & Secretary Timothy Ernst Sells 2,500 Shares of Bio-Rad ...
GuruFocus.com via Yahoo Finance· 2 months agoBio-Rad Laboratories Inc (NYSE:BIO), a global leader in the life science research and clinical...
Bio-Rad (BIO) Beats on Q2 Earnings Estimates, Cuts 2023 View
Zacks via Yahoo Finance· 9 months agoBio-Rad Laboratories, Inc. BIO posted second-quarter 2023 adjusted earnings per share (EPS) of...